1
Clinical Trials associated with Tuberculosis vaccine(Oxxon Therapeutics, Inc.)A phase II observer blind, randomised, controlled study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ candidate tuberculosis vaccine GSK 692342 when administered to adults aged 18 to 59 years with TB disease - TUBERCULOSIS-017
100 Clinical Results associated with Tuberculosis vaccine(Oxxon Therapeutics, Inc.)
100 Translational Medicine associated with Tuberculosis vaccine(Oxxon Therapeutics, Inc.)
100 Patents (Medical) associated with Tuberculosis vaccine(Oxxon Therapeutics, Inc.)
5
Literatures (Medical) associated with Tuberculosis vaccine(Oxxon Therapeutics, Inc.)01 Jan 2010·Revista Portuguesa de Pneumologia
Uma nova vacina viva contra a tuberculose com base na inativação do phoP
Article
Author: Marinova, Dessi ; Martín, Carlos ; Arbues, Ainhoa ; Asensio, Jesus Gonzalo
01 Sep 2007·Revista de Saúde PúblicaQ4 · MEDICINE
Vacina BCG contra tuberculose: efeito protetor e políticas de vacinação
Q4 · MEDICINE
ReviewOA
Author: Dantas, Odimariles Maria Souza ; Pereira, Susan M ; Barreto, Mauricio L ; Ximenes, Ricardo
01 Jan 1968·Bibliotheca tuberculosea
Nonliving immunogenic substances of Mycobacteria.
Review
Author: Grover, A A ; Wiegeshaus, E ; Smith, D W
100 Deals associated with Tuberculosis vaccine(Oxxon Therapeutics, Inc.)